COSENTYX

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: be81c017c3a73abb
Drug Approval Canada Name: COSENTYX
Product Name: COSENTYX
Status: Marketed
Status Date: 2022-06-02
Original Market Date: 2022-06-02
Din: 02525569
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.20.92
Atc Original: L04AC10 SECUKINUMAB
Atc Name: l 04 ac 10
Aig Number: 0156650001
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

SECUKINUMAB

75 MG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

be81c017c3a73abb

Type

Standard